Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gildas Baulier

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
La Revue Du Praticien|December 5, 2018
[Acute pancreatitis]Gildas Baulier, Issa Nahema
La Revue Du Praticien|March 19, 2021
[Granulomatosis with polyangiitis]Gildas Baulier, Salomé Georgiou
The Journal of Allergy and Clinical Immunology. in Practice|May 13, 2019
Romidepsin is an effective and well-tolerated therapy in CD3<sup>-</sup>CD4<sup>+</sup> lymphocyte-variant hypereosinophilic syndrome: A case reportGildas Baulier, Bouchra Asli, Lionel Galicier, et al.
Clinical and Experimental Rheumatology|March 14, 2018
Guidelines for prophylaxis of Pneumocystis pneumonia cannot rely solely on CD4-cell count in autoimmune and inflammatory diseasesGildas Baulier, Nahema Issa, Frederic Gabriel, et al.
La Revue De Medecine Interne|July 15, 2020
Félix Blaison, Déborah Faganello, Camille Goigoux, et al.
Annals of Hematology|March 5, 2019
Successful management of transcatheter aortic valve implantation by platelet transfusions in a nonagenarian patient with severe autoimmune factor V deficiencyChristine Mouton, Lionel Leroux, Guillaume Bonnet, et al.
Eclinicalmedicine|June 6, 2024
Long-term outcome and prognosis of mixed histiocytosis (Erdheim-Chester disease and Langerhans Cell Histiocytosis)Francesco Pegoraro, Matthias Papo, Fleur Cohen-Aubart, et al.
RMD Open|November 1, 2022
Tolerance and efficacy of targeted therapies prescribed for off-label indications in refractory systemic autoimmune diseases: data of the first 100 patients enrolled in the TATA registry (TArgeted Therapy in Autoimmune Diseases)Jacques-Eric Gottenberg, Aurore Chaudier, Yves Allenbach, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
La Revue Du Praticien|December 5, 2018
[Acute pancreatitis]Gildas Baulier, Issa Nahema
La Revue Du Praticien|March 19, 2021
[Granulomatosis with polyangiitis]Gildas Baulier, Salomé Georgiou
The Journal of Allergy and Clinical Immunology. in Practice|May 13, 2019
Romidepsin is an effective and well-tolerated therapy in CD3<sup>-</sup>CD4<sup>+</sup> lymphocyte-variant hypereosinophilic syndrome: A case reportGildas Baulier, Bouchra Asli, Lionel Galicier, et al.
Clinical and Experimental Rheumatology|March 14, 2018
Guidelines for prophylaxis of Pneumocystis pneumonia cannot rely solely on CD4-cell count in autoimmune and inflammatory diseasesGildas Baulier, Nahema Issa, Frederic Gabriel, et al.
La Revue De Medecine Interne|July 15, 2020
Félix Blaison, Déborah Faganello, Camille Goigoux, et al.
Annals of Hematology|March 5, 2019
Successful management of transcatheter aortic valve implantation by platelet transfusions in a nonagenarian patient with severe autoimmune factor V deficiencyChristine Mouton, Lionel Leroux, Guillaume Bonnet, et al.
Eclinicalmedicine|June 6, 2024
Long-term outcome and prognosis of mixed histiocytosis (Erdheim-Chester disease and Langerhans Cell Histiocytosis)Francesco Pegoraro, Matthias Papo, Fleur Cohen-Aubart, et al.
RMD Open|November 1, 2022
Tolerance and efficacy of targeted therapies prescribed for off-label indications in refractory systemic autoimmune diseases: data of the first 100 patients enrolled in the TATA registry (TArgeted Therapy in Autoimmune Diseases)Jacques-Eric Gottenberg, Aurore Chaudier, Yves Allenbach, et al.
Pageof 1